301033 Stock Overview
Medprin Regenerative Medical Technologies Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 301033 from our risk checks.
Medprin Regenerative Medical Technologies Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥47.92 |
| 52 Week High | CN¥57.32 |
| 52 Week Low | CN¥22.37 |
| Beta | -0.13 |
| 11 Month Change | 5.55% |
| 3 Month Change | 18.61% |
| 1 Year Change | 10.16% |
| 33 Year Change | -27.12% |
| 5 Year Change | n/a |
| Change since IPO | -32.54% |
Recent News & Updates
Shareholder Returns
| 301033 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -7.8% | -5.6% | -6.7% |
| 1Y | 10.2% | -10.2% | 1.9% |
Return vs Industry: 301033 exceeded the CN Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: 301033 matched the CN Market which returned 4% over the past year.
Price Volatility
| 301033 volatility | |
|---|---|
| 301033 Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 301033 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301033's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 278 | Jianhua Wang | www.medprin.com |
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers dura membrane patches, regenerated oxidized cellulose, and craniomaxillofacial repair systems.
Medprin Regenerative Medical Technologies Co., Ltd. Fundamentals Summary
| 301033 fundamental statistics | |
|---|---|
| Market cap | CN¥3.06b |
| Earnings (TTM) | CN¥68.26m |
| Revenue (TTM) | CN¥276.03m |
46.1x
P/E Ratio11.4x
P/S RatioIs 301033 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301033 income statement (TTM) | |
|---|---|
| Revenue | CN¥276.03m |
| Cost of Revenue | CN¥55.50m |
| Gross Profit | CN¥220.53m |
| Other Expenses | CN¥152.28m |
| Earnings | CN¥68.26m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.04 |
| Gross Margin | 79.89% |
| Net Profit Margin | 24.73% |
| Debt/Equity Ratio | 0.2% |
How did 301033 perform over the long term?
See historical performance and comparison